好色先生

好色先生

Explore the latest content from across our publications
Join The AAN

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

mHealth Interventions: Lots on the Market but are they Studied? An Analysis of mHealth Interventions for Neuropsychiatric Conditions
Research Methodology, 好色先生, and History
P1 - Poster Session 1 (5:30 PM-6:30 PM)
4-068
Given the explosion of mHealth interventions, we sought to systematically study the (1) number of mHealth interventions using smartphones being studied, (2) trends in when these studies are being initiated, and (3) reporting of results for the top ten most disabling neuropsychiatric conditions per the World Health Organization (WHO). 
The development of mHealth technologies is currently progressing at a faster pace than the science to evaluate their validity and efficacy. Under the International Committee of Journal Medical Editors (ICJME) guidelines, clinical trials that prospectively assign people to interventions should be registered with a database prior to the initiation of the study. 
Using the WHO DALYS, we selected the top 10 most disabling neuropsychiatric conditions and conducted a systematic search of clinicaltrials.gov for these conditions along with the following search terms: smartphone, electronic, mHealth to evaluate the research being conducted and reported on these neuropsychiatric conditions with smartphone based interventions. There were no date, location, or status restrictions.
59 studies met the search criteria. Studies using smartphones were conducted for the following neuropsychiatric conditions in descending order: Stroke (9), Schizophrenia (8), Other Mental and Substance Use Disorders (7), Major Depressive Disorder (7), Anxiety Disorders (7), Alcohol Use Disorders (7), Opioid Use Disorders (4), Migraine (4), Epilepsy (3) and Alzheimer Disease/Other Dementias (3). Studies were first registered in 2011, with more than half registered between 2016-2018. Of the 59 studies included, only 8 studies reported their results, two of which published papers in peer reviewed journals. 
Despite the increasing use of health-based smartphone applications by the general public, few are clinically evaluated. Moreover, only 14% report their results.  Interestingly, there were few studies for the most disabling neuropsychiatric conditions that typically use e-diaries for self-management-migraine and epilepsy. 
Authors/Disclosures

PRESENTER 		No disclosure on file
Pallavi Pemmireddy No disclosure on file
No disclosure on file
Mia T. Minen, MD, FAAN (NYULMC Neurology) The institution of Dr. Minen has received research support from NIH. Dr. Minen has received intellectual property interests from a discovery or technology relating to health care. Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a First Contact-Primary Care Advisory Board Member with American Headache Society . Dr. Minen has received personal compensation in the range of $500-$4,999 for serving as a Consultant for PCORI grant on migraine evidence based map for stakeholders with ECRI .